CSPC Pharmaceutical Group Limited

CSPCY | OTC

$4.07

+$0.13 (+3.30%)

Nov 2, 2026, 10:20 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
PE Ratio	25.55	12.58	14.52	15.77	18.41	19.34
PEG Ratio	-1.94	-0.52	-3.78	1.21	1.51	0.37
PS Ratio	3.80	1.90	2.74	3.09	3.69	4.02
PB Ratio	2.90	1.74	2.60	3.28	3.90	4.26
P/FCF Ratio	24.15	32.19	37.71	14.76	35.18	19.07
P/OCF Ratio	16.33	13.17	20.63	12.06	21.84	14.68
OCF/S Ratio	23.28	14.42	13.28	25.64	16.92	27.38
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0	0.02
Quick Ratio	1.88	1.95	2.32	2.39	2.47	2.23
Current Ratio	2.19	2.27	2.63	2.67	2.81	2.53
Asset Turnover	0.54	0.67	0.68	0.77	0.79	0.79
Interest Coverage	102.89	124.82	270.52	278.45	801.40	420
Return on Equity	11.39%	13.67%	17.70%	20.89%	21.25%	21.90%
Return on Assets	8.09%	9.93%	12.70%	15.10%	15.90%	16.26%
Return on Invested Capital	8.43%	12.05%	15.69%	17.21%	18.53%	17.47%
Dividend Yield	2.53%	5.87%	3.48%	2.15%	1.64%	1.36%
Payout Ratio	64.33%	74.72%	51.03%	33.71%	30.16%	26.35%
FCF Payout Ratio	60.01%	213.10%	147.96%	32.45%	58.06%	25.90%
Gross Profit Margin	65.59%	69.97%	70.51%	71.94%	75.84%	74.91%
Net Profit Margin	14.93%	14.92%	18.68%	19.69%	20.11%	20.69%
Pretax Profit Margin	18.49%	19.23%	23.50%	24.51%	24.57%	25.62%
Operating Profit Margin	15.27%	18.45%	22.26%	21.94%	22.41%	21.79%
FCF Margin	15.74%	5.90%	7.26%	20.96%	10.50%	21.08%
EBITDA Margin	20.69%	24.30%	27.29%	28.02%	27.62%	28.85%